Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilator Efficacy of Tiotropium/Salmeterol/Fluticasone FDC via Discair vs Free Combination in COPD
NCT03395002Phase 4Completed
- Sponsor
- Neutec Group
- Start
- Mar 2018
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium, salmeterol, fluticasone propionate nasal spray in chronic obstructive pulmonary disease (COPD), sponsored by Neutec Group. Started Mar 2018; status: completed.
02
Drugs
tiotropiumsalmeterolfluticasone propionate nasal spray
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03395002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395002.